Filing Details

Accession Number:
0001567619-22-021876
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-20 18:22:25
Reporting Period:
2022-12-20
Accepted Time:
2022-12-20 18:22:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626971 Corvus Pharmaceuticals Inc. CRVS Pharmaceutical Preparations (2834) 464670809
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1664506 Benton William Jones C/O Corvus Pharmaceuticals, Inc.
863 Mitten Road, Suite 102
Burlingame CA 94010
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-20 20,000 $0.79 133,773 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct